Platelet activation factor analogs and antagonists

Achievements and prospects in the creation of antiaggregative drugs (Review)

“…-molecules of TAF antagonists may not contain a glycerin ~ent, but has to be sterically similar to the TAF molecule; the structure of TAF antagonist must contain two electronegative fragments oriented so as to make an angle of 180 ~ relative to one another [50].…”